March 7, 2018 / 12:35 PM / 7 months ago

BRIEF-Idera Pharmaceuticals Reports Q4 Loss Per Share $0.08

March 7 (Reuters) - Idera Pharmaceuticals Inc:

* IDERA PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 LOSS PER SHARE $0.08

* IDERA PHARMACEUTICALS -AS OF DEC 31, 2017, OUR CASH, CASH EQUIVALENTS AND INVESTMENTS TOTALED $112.6 MILLION COMPARED TO $109.0 MILLION AS OF DEC 31, 2016

* DEVELOPMENT DECISION FOR IDRA-008 EXPECTED DURING Q2 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below